Autoimmune Pulmonary Alveolar Proteinosis with Suspected Exacerbation after Osimertinib Administration for Lung Cancer

A 46-year-old woman with lung cancer who received chemotherapy was admitted to our hospital for lower-lobe bilateral ground-glass opacity (GGO). GGO developed after the lung cancer diagnosis, deteriorated after the initiation of osimertinib, and incompletely decreased after interrupting osimertinib;...

Descripción completa

Detalles Bibliográficos
Autores principales: Shimoda, Masafumi, Ishii, Haruyuki, Tanaka, Yoshiaki, Morimoto, Kozo, Takemura, Tamiko, Oka, Teruaki, Yoshimori, Kozo, Ohta, Ken
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Japanese Society of Internal Medicine 2022
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183281/
https://www.ncbi.nlm.nih.gov/pubmed/36070942
http://dx.doi.org/10.2169/internalmedicine.0256-22

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10183281/
https://www.ncbi.nlm.nih.gov/pubmed/36070942
http://dx.doi.org/10.2169/internalmedicine.0256-22

Ejemplares similares